BioCentury | Jan 25, 2020
Company News

Pfizer seeking to dent market share with trio of discounted biosimilars

...OTCQX:RHHBY). Targets: HER2 (EGFR2; ErbB2; neu) - Epidermal growth factor receptor 2 Paul Bonanos, Associate Editor Zirabev, biosimilar bevacizumab...
BioCentury | Jul 19, 2019
Company News

July 19 Company Quick Takes: First biosimilars of Avastin, Herceptin launched; plus Gilenya, Celltrion-Nan Fung and Celgene

...CT-P26, CT-P06) Inflectra, Remsima, biosimilar infliximab-dyyb (CT-P13) Kanjinti, biosimilar trastuzumab (ABP 980) Mvasi (Brand), ABP 215 (Compound #), biosimilar bevacizumab...
BioCentury | Jun 28, 2019
Company News

June 28 Company Quick Takes: FDA approves Pfizer's biosimilar of Avastin; plus Aimmune, PeptiDream, Novartis and Just/Teva

...S. Eaton, Staff Writer AR101, arc001, peanut allergy oral immunotherapy (oit) Avastin, bevacizumab (RG435, Anti-VEGF antibody, R435) Zirabev, biosimilar bevacizumab...
BioCentury | Dec 21, 2018
Clinical News

CHMP backs Besremi for polycythemia vera, two Shionogi drugs

...Business: Hematology; gastrointestinal; infectious; cancer; cardiovascular Sandi Wong Adcetris (Brand), SGN-35 (Compound #), brentuximab vedotin (Generic), Adcetris (Other) biosimilar bevacizumab...
BioCentury | Dec 14, 2018
Company News

CHMP backs Besremi for polycythemia vera, two Shionogi drugs

...negative opinions in its monthly roundup. Sandi Wong Adcetris (Brand), SGN-35 (Compound #), brentuximab vedotin (Generic), Adcetris (Other) biosimilar bevacizumab...
BioCentury | Jun 1, 2018
Financial News

JHL raises $106M in bond deal

...testing in Europe. Avastin is a humanized mAb against VEGF. JHL Biotech Inc., Zhubei, Taiwan Chris Lieu Biosimilar bevacizumab...
BioCentury | May 30, 2018
Financial News

JHL raises $106M in bond deal

...is already in Phase I testing in Europe. Avastin is a humanized mAb against VEGF. Chris Lieu Biosimilar bevacizumab...
BioCentury | Jan 19, 2018
Clinical News

EC approves Amgen's biosimilar Avastin

...market Avastin. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Allergan plc (NYSE:AGN), Dublin, Ireland Product: Mvasi biosimilar bevacizumab...
BioCentury | Nov 17, 2017
Clinical News

CHMP recommends Amgen's Avastin biosimilar ABP 215

...marketing reasons." Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Allergan plc (NYSE:AGN), Dublin, Ireland Product: Mvasi biosimilar bevacizumab...
BioCentury | Sep 15, 2017
Clinical News

FDA approves first biosimilar for cancer

...against VEGF. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Allergan plc (NYSE:AGN), Dublin, Ireland Product: Mvasi biosimilar bevacizumab...
Items per page:
1 - 10 of 23